MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$44,727K
EPS
-$0.76
Unit: Thousand (K) dollars
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
License revenue
-
20,000
-
-
Research and development
34,940
34,148
28,501*
25,190
General and administrative
13,095
12,405
10,240*
7,775
Total operating expenses
48,035
46,553
38,740
32,965
Loss from operations
-48,035
-26,553
-38,740*
-32,965
Interest and other income, net
4,239
3,211
3,270*
2,878
Interest expense
931
866
-
-
(loss) income before income tax expense
-
-
-35,471
-30,087
Total other income, net
3,308
2,345
-
-
Net loss
-44,727
-24,208
-35,471
-30,087
Basic EPS
-0.76
-0.45
-0.901
-0.66
Diluted EPS
-0.76
-0.45
-0.901
-0.66
Basic Average Shares
58,995,934
53,897,216
39,351,074
45,779,577
Diluted Average Shares
58,995,934
53,897,216
39,351,074
45,779,577
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest and other
income, net
$4,239K
(51.66%↑ Y/Y)
Net loss
-$44,727K
(-32.80%↓ Y/Y)
Total other income,
net
$3,308K
Interest expense
$931K
Loss from operations
-$48,035K
(-31.70%↓ Y/Y)
Total operating
expenses
$48,035K
(31.70%↑ Y/Y)
Research and development
$34,940K
(24.31%↑ Y/Y)
General and
administrative
$13,095K
(56.53%↑ Y/Y)
Buy us a coffee
Maze Therapeutics, Inc. (MAZE)
Maze Therapeutics, Inc. (MAZE)